TLR4 and neoplasm: The release of HMGB1 enhances the immunogenicity of apoptotic cells [147], and when HMGB1 is secreted by dying tumor cells, it augments tumor-specific immune responses through toll-like receptor 4 (TLR4) signaling [148].